EGFR/VEGFR2-IN-9
EGFR/VEGFR2-IN-9 (Compound 9b) is an inhibitor of VEGFR-2 (IC50 = 1.325 μM) and EGFR (IC50 = 1.891 μM). EGFR/VEGFR2-IN-9 significantly inhibits the proliferation of multiple cancer cell lines, particularly leukemia cells. EGFR/VEGFR2-IN-9 upregulates the expression levels of Bax, caspase-3, and p53, while downregulating the expression of Bcl-2. EGFR/VEGFR2-IN-9 induces apoptosis and arrests the cell cycle in the G1 phase. EGFR/VEGFR2-IN-9 can be used to investigate anti-tumor angiogenesis and multi-drug resistant cancers.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Fòrmula: C25H23ClN6O3
- Peso molecular:490.94
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas VEGFR
MoreVer todos los productos específicos de isoformas EGFR
MoreVer todos los productos específicos de isoformas Caspase
More
Actividad biológica
|
EGFR 1.891 μM (IC50) |
Bax |
Caspase 3 |
Bcl-2 |
Chemical Information
-
Peso molecular 490.94
-
Fòrmula C25H23ClN6O3
-
SMILES
COC(C=C12)=C(OC)C=C1N=CN=C2NC(C=C3)=CC=C3/C(C)=N/NC(NC4=CC=C(Cl)C=C4)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)